Product Code: ETC7335873 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Psoriasis Drugs Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Psoriasis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Psoriasis Drugs Market - Industry Life Cycle |
3.4 Ghana Psoriasis Drugs Market - Porter's Five Forces |
3.5 Ghana Psoriasis Drugs Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.6 Ghana Psoriasis Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
4 Ghana Psoriasis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about psoriasis and its treatment options in Ghana |
4.2.2 Growing healthcare infrastructure and access to healthcare services in the country |
4.2.3 Rising disposable income and healthcare spending per capita among the Ghanaian population |
4.3 Market Restraints |
4.3.1 Limited availability of advanced treatment options and medications for psoriasis in Ghana |
4.3.2 High cost of psoriasis drugs and treatments, limiting affordability for a significant portion of the population |
4.3.3 Lack of specialized healthcare professionals and dermatologists with expertise in managing psoriasis cases in Ghana |
5 Ghana Psoriasis Drugs Market Trends |
6 Ghana Psoriasis Drugs Market, By Types |
6.1 Ghana Psoriasis Drugs Market, By Therapeutic Class |
6.1.1 Overview and Analysis |
6.1.2 Ghana Psoriasis Drugs Market Revenues & Volume, By Therapeutic Class, 2021- 2031F |
6.1.3 Ghana Psoriasis Drugs Market Revenues & Volume, By Tumor Necrosis Factor Inhibitor, 2021- 2031F |
6.1.4 Ghana Psoriasis Drugs Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.2 Ghana Psoriasis Drugs Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Ghana Psoriasis Drugs Market Revenues & Volume, By Topicals, 2021- 2031F |
6.2.3 Ghana Psoriasis Drugs Market Revenues & Volume, By Systemic, 2021- 2031F |
6.2.4 Ghana Psoriasis Drugs Market Revenues & Volume, By Biologics, 2021- 2031F |
7 Ghana Psoriasis Drugs Market Import-Export Trade Statistics |
7.1 Ghana Psoriasis Drugs Market Export to Major Countries |
7.2 Ghana Psoriasis Drugs Market Imports from Major Countries |
8 Ghana Psoriasis Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed psoriasis treatments |
8.2 Number of clinical trials and research studies conducted on psoriasis drugs in Ghana |
8.3 Percentage of healthcare facilities offering specialized care for psoriasis patients |
9 Ghana Psoriasis Drugs Market - Opportunity Assessment |
9.1 Ghana Psoriasis Drugs Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
9.2 Ghana Psoriasis Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10 Ghana Psoriasis Drugs Market - Competitive Landscape |
10.1 Ghana Psoriasis Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ghana Psoriasis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |